DR. Elisabeth Lackner

Chief Executive Officer

“Together, we aim to propel CRS to new heights, centred on internationalization, strategic expansion, and a relentless pursuit of excellence."

 

Dr. Lackner is a highly experienced and well-respected global thought leader with over 20 years of experience in the healthcare industry. 

She joins from Element Materials where she held the CSO position, responsible for driving technical excellence and ensuring continued scientific rigor across the business, accelerating growth and increasing the company’s global presence. Prior to this, she was Managing Director at Vineta, a family office focusing on long-term investments in Life Sciences. Previously, she led the merger of ABF Pharmaceutical Services and GBA Group Pharma, serving as the CEO of the GBA Pharma Division. As CEO, she turned the company from a national vendor into a trusted international partner for the pharma and biotech industries. 

Dr. Lackner also serves as a QP (Qualified Person) and is a respected advisor within the life sciences industry. She obtained a PhD in Pharmacy from the University of Vienna and a Master’s degree in Tumor Biology. She holds several board positions of listed and non-listed companies.